Phibro Animal Health (PAHC)

Nasdaq Health Care Pharmaceuticals S&P SmallCap 600

$32.96

-2.44 (-6.89%)

Close of Nov 06, 2026 · end-of-day data

Source: Phibro Animal Health's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$764.28M	$819.98M	$828.00M	$800.35M	$833.35M	$942.26M	$977.89M	$1.02B	$1.30B	$1.52B
Cost of revenue	$516.04M	$553.10M	$563.37M	$543.47M	$561.97M	$656.86M	$679.65M	$704.59M	$896.27M	$1.01B
Gross profit	$248.24M	$266.88M	$264.62M	$256.88M	$271.38M	$285.40M	$298.24M	$313.09M	$399.94M	$512.51M
Research & development	$9.44M	$10.00M	$12.09M	$13.74M	$17.76M	$20.83M	$24.39M	$29.19M	$23.73M	$24.55M
Selling, general & admin	$150.31M	$167.95M	$181.40M	$187.69M	$196.51M	$206.41M	$226.39M	$259.78M	$289.48M	$318.12M
Operating income	$97.93M	$98.93M	$83.23M	$69.19M	$74.87M	$78.99M	$71.85M	$53.31M	$110.47M	$194.40M
Interest expense	$16.87M	$13.60M	$13.68M	$14.61M	$13.72M	$12.69M	$18.68M	$23.01M	$37.22M	$46.42M
Pre-tax income	$80.54M	$88.07M	$71.50M	$55.51M	$66.47M	$72.33M	$54.07M	$10.92M	$67.99M	$137.35M
Income tax	$15.93M	$23.19M	$16.79M	$21.96M	$12.08M	$23.15M	$21.46M	$8.50M	$19.73M	$37.63M
Net income	$64.61M	$64.88M	$54.71M	$33.55M	$54.38M	$49.17M	$32.61M	$2.42M	$48.26M	$99.72M
EBITDA	$123.94M	$125.87M	$110.79M	$101.53M	$106.75M	$111.69M	$105.86M	$89.49M	$156.07M	$245.91M
EPS (basic)	$1.63	$1.61	$1.35	$0.83	$1.34	$1.21	$0.81	$0.06	$1.19	$2.46
EPS (diluted)	$1.61	$1.61	$1.35	$0.83	$1.34	$1.21	$0.81	$0.06	$1.19	$2.43
Diluted shares	40.04K	40.38K	40.52K	40.50M	40.50M	40.50M	40.50M	40.52M	40.68M	40.96M
Gross margin	32.5%	32.5%	32.0%	32.1%	32.6%	30.3%	30.5%	30.8%	30.9%	33.8%
Operating margin	12.8%	12.1%	10.1%	8.6%	9.0%	8.4%	7.3%	5.2%	8.5%	12.8%
Net margin	8.5%	7.9%	6.6%	4.2%	6.5%	5.2%	3.3%	0.2%	3.7%	6.6%

Balance sheet

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash & equivalents	$56.08M	$29.17M	$57.57M	$36.34M	$50.21M	$74.25M	$41.28M	$70.61M	$68.04M	$61.42M
Short-term investments	—	$50.00M	$24.00M	$55.00M	$43.00M	$17.00M	$40.00M	$44.00M	$9.00M	$20.57M
Receivables	$125.85M	$135.74M	$159.02M	$126.52M	$146.85M	$166.54M	$163.48M	$169.45M	$227.98M	$238.79M
Inventory	$161.23M	$178.17M	$198.32M	$196.66M	$216.31M	$259.16M	$277.57M	$265.91M	$444.43M	$534.88M
Total current assets	$363.67M	$415.46M	$466.16M	$451.84M	$498.91M	$566.23M	$585.72M	$601.00M	$810.61M	$935.51M
Goodwill	$23.98M	$27.35M	$27.35M	$52.68M	$52.68M	$53.23M	$53.27M	$54.56M	$59.65M	$60.05M
Total assets	$623.40M	$671.68M	$726.67M	$784.10M	$841.33M	$931.70M	$971.40M	$982.18M	$1.36B	$1.50B
Total current liabilities	$115.80M	$143.22M	$154.23M	$157.24M	$164.12M	$190.83M	$176.00M	$204.15M	$293.47M	$316.47M
Short-term debt	$6.25M	$12.58M	$12.54M	$18.75M	$9.38M	$15.00M	$22.30M	$29.80M	$16.25M	$25.02M
Long-term debt	$241.89M	$229.80M	$217.63M	$218.01M	$297.08M	$272.93M	$311.54M	$282.29M	$615.43M	$591.77M
Total debt	$248.14M	$242.38M	$230.18M	$236.76M	$306.46M	$287.93M	$333.84M	$312.08M	$631.68M	$616.79M
Total liabilities	$472.24M	$486.73M	$510.66M	$595.90M	$602.80M	$669.26M	$688.89M	$725.54M	$1.08B	$1.12B
Shareholders' equity	$151.16M	$184.95M	$216.01M	$188.20M	$238.53M	$262.44M	$282.51M	$256.64M	$285.68M	$385.48M

Cash flow

fiscal years · USD

Fiscal year	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Operating cash flow	$98.39M	$70.01M	$47.17M	$59.35M	$48.31M	$31.65M	$13.31M	$87.59M	$80.12M	$68.95M
Capital expenditures	$20.88M	$18.55M	$29.89M	$34.05M	$29.32M	$37.04M	$51.79M	$41.24M	$38.29M	$59.09M
Free cash flow	$77.50M	$51.46M	$17.28M	$25.30M	$18.99M	-$5.39M	-$38.48M	$46.36M	$41.83M	$9.87M
Investing cash flow	-$21.94M	-$84.61M	-$14.13M	-$120.39M	-$18.58M	-$22.58M	-$74.02M	-$48.19M	-$288.69M	-$71.45M
Financing cash flow	-$53.74M	-$11.78M	-$4.11M	$40.94M	-$17.00M	$16.34M	$26.99M	-$6.77M	$207.13M	-$6.56M
Dividends paid	$15.83M	$16.07M	$18.59M	$19.42M	$19.43M	$19.44M	$19.44M	$19.44M	$19.45M	$19.46M
Stock-based compensation	$0	$334.00K	$2.26M	$2.26M	$1.13M	—	—	$475.00K	$717.00K	$1.60M
Depreciation & amortization	$26.00M	$26.94M	$27.56M	$32.34M	$31.89M	$32.70M	$34.01M	$36.18M	$45.60M	$51.51M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$249.94M	$263.22M	$273.16M	$260.43M	$309.26M	$347.82M	$378.70M	$363.89M	$373.91M	$383.54M	$396.75M	$386.77M
Cost of revenue	$171.33M	$183.62M	$186.01M	$176.94M	$207.39M	$243.26M	$268.69M	$244.11M	$241.25M	$257.87M	$262.35M	$258.24M
Gross profit	$78.62M	$79.60M	$87.15M	$83.50M	$101.87M	$104.57M	$110.01M	$119.78M	$132.66M	$125.67M	$134.40M	$128.54M
Selling, general & admin	$62.91M	$59.68M	$68.73M	$65.80M	$76.34M	$71.05M	$76.29M	$68.52M	$82.33M	$81.02M	$86.24M	$78.90M
Operating income	$15.70M	$19.92M	$18.42M	$17.70M	$25.53M	$33.52M	$33.72M	$51.26M	$50.33M	$44.65M	$48.16M	$49.64M
Interest expense	$5.72M	$5.64M	$6.00M	$8.77M	$9.78M	$9.65M	$9.03M	$12.54M	$12.48M	$10.68M	$10.71M	$12.25M
Pre-tax income	$3.56M	$12.92M	$6.41M	$9.62M	$4.84M	$29.69M	$23.85M	$36.27M	$36.42M	$32.31M	$32.34M	$38.78M
Income tax	$2.29M	$4.52M	$5.66M	$2.65M	$1.65M	$8.81M	$6.62M	$9.74M	$8.97M	$8.29M	$10.63M	$9.26M
Net income	$1.27M	$8.40M	$752.00K	$6.97M	$3.19M	$20.88M	$17.22M	$26.53M	$27.46M	$24.02M	$21.71M	$29.52M
EBITDA	$24.61M	$29.12M	$27.62M	$26.70M	$37.11M	$46.13M	$46.13M	$64.09M	$63.22M	$57.10M	$61.50M	$63.22M
EPS (basic)	$0.03	$0.21	$0.02	$0.17	$0.08	$0.52	$0.42	$0.65	$0.68	$0.59	$0.54	$0.73
EPS (diluted)	$0.03	$0.21	$0.02	$0.17	$0.08	$0.51	$0.43	$0.65	$0.67	$0.59	$0.53	$0.72
Diluted shares	40.50M	40.52M	14.00K	40.58M	40.72M	40.71M	9.00K	40.88M	40.96M	41.04M	8.00K	40.96M
Gross margin	31.5%	30.2%	31.9%	32.1%	32.9%	30.1%	29.0%	32.9%	35.5%	32.8%	33.9%	33.2%
Operating margin	6.3%	7.6%	6.7%	6.8%	8.3%	9.6%	8.9%	14.1%	13.5%	11.6%	12.1%	12.8%
Net margin	0.5%	3.2%	0.3%	2.7%	1.0%	6.0%	4.5%	7.3%	7.3%	6.3%	5.5%	7.6%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$32.97M	$50.23M	$70.61M	$51.84M	$67.07M	$60.35M	$68.04M	$72.77M	$55.49M	$54.93M	$61.42M	$75.55M
Short-term investments	$59.52M	$48.52M	$44.00M	$38.00M	$0	$10.00M	$9.00M	$12.50M	$19.02M	$22.52M	$20.57M	$7.58M
Receivables	$150.63M	$161.09M	$169.45M	$160.78M	$191.79M	$197.52M	$227.98M	$217.90M	$215.87M	$221.55M	$238.79M	$221.71M
Inventory	$286.68M	$282.29M	$265.91M	$272.56M	$427.22M	$448.39M	$444.43M	$471.77M	$517.35M	$539.70M	$534.88M	$567.14M
Total current assets	$586.59M	$597.18M	$601.00M	$570.77M	$746.15M	$776.02M	$810.61M	$835.80M	$862.18M	$894.07M	$935.51M	$945.17M
Goodwill	$54.68M	$54.64M	$54.56M	$54.59M	$54.55M	$54.57M	$59.65M	$59.71M	$59.81M	$59.89M	$60.05M	$60.03M
Total assets	$972.71M	$979.03M	$982.18M	$966.29M	$1.29B	$1.32B	$1.36B	$1.39B	$1.41B	$1.45B	$1.50B	$1.51B
Total current liabilities	$187.74M	$189.07M	$204.15M	$176.89M	$233.25M	$266.48M	$293.47M	$270.14M	$282.37M	$281.87M	$316.47M	$295.79M
Short-term debt	$26.05M	$29.81M	$29.80M	$7.50M	$16.25M	$16.25M	$16.25M	$18.44M	$20.64M	$22.83M	$25.02M	$25.02M
Long-term debt	$297.85M	$291.01M	$282.29M	$287.67M	$622.88M	$619.16M	$615.43M	$609.52M	$603.60M	$597.68M	$591.77M	$585.85M
Total debt	$323.90M	$320.82M	$312.08M	$295.17M	$639.13M	$635.41M	$631.68M	$627.96M	$624.24M	$620.52M	$616.79M	$610.88M
Total liabilities	$701.90M	$708.94M	$725.54M	$707.76M	$1.04B	$1.05B	$1.08B	$1.07B	$1.07B	$1.08B	$1.12B	$1.10B
Shareholders' equity	$270.80M	$270.09M	$256.64M	$258.53M	$246.80M	$265.99M	$285.68M	$311.68M	$332.36M	$361.83M	$385.48M	$417.67M

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$31.56M	$11.41M	$28.43M	$12.62M	$3.08M	$43.15M	$21.27M	$9.30M	$19.35M	$16.21M	$24.09M	$26.08M
Capital expenditures	$10.96M	$9.73M	$13.07M	$9.58M	$7.82M	$7.75M	$13.14M	$13.81M	$11.10M	$15.32M	$18.87M	$18.78M
Free cash flow	$20.60M	$1.68M	$15.36M	$3.04M	-$4.75M	$35.41M	$8.13M	-$4.50M	$8.26M	$890.00K	$5.22M	$7.30M
Investing cash flow	-$24.86M	$1.13M	-$9.11M	-$2.93M	-$260.47M	-$18.25M	-$7.03M	-$21.01M	-$17.18M	-$16.81M	-$16.45M	-$5.95M
Financing cash flow	-$14.71M	$4.85M	$1.79M	-$29.20M	$276.32M	-$32.22M	-$7.77M	$16.34M	-$18.98M	-$2.30M	-$1.61M	-$5.63M
Dividends paid	$4.86M	$4.86M	$4.86M	$4.86M	$4.86M	$4.87M	$4.86M	$4.86M	$4.86M	$4.87M	$4.87M	$4.87M
Stock-based compensation	$80.00K	$135.00K	$179.00K	$179.00K	$180.00K	$179.00K	$179.00K	$339.00K	$434.00K	$411.00K	$413.00K	$804.00K
Depreciation & amortization	$8.91M	$9.20M	$9.20M	$9.00M	$11.57M	$12.62M	$12.41M	$12.83M	$12.89M	$12.45M	$13.35M	$13.58M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.